Date of download: 6/22/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Notes: aHepatitis B vaccine (HepB). AT BIRTH: All newborns should.

Slides:



Advertisements
Similar presentations
2010 National Immunization Survey Report, Texas Child and Teen Vaccination Coverage Levels Jack Sims-Immunization Branch Manager Tony Aragon, MS-Epidemiologist.
Advertisements

Feb 2011 Dr Guada Lopez Marti Pediatric Infectious Diseases Marshall University.
Meningococcemia: Epidemiology & Prevention Baylor College of Medicine Med-Peds Continuity Clinic Anoop Agrawal, M.D.
Communicable Diseases & Vaccinations
Immunizations Rodolfo E. Bégué, MD Chief, Infectious Diseases Pediatrics, LSUHSC
Immunization Update Andrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases Andrew Kroger, MD, MPH National Center for Immunization.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Implementing WA New State Exemption Requirements - Training for Schools and Child Cares/Preschools August XX, 2011 Preschool/Child Care Immunization Requirements.
ACIP Meeting Update November 4 th
Practical Challenges to Adolescent Immunization Society for Adolescent Health and Medicine Conference, Los Angeles 2015.
 Definition of Immunization  Immunization Schedule  Success of Immunization Assessment of Success Factors Influencing Success  The Cold Chain.
School Based Immunization Campaign
Tricia Washburn Rhode Island Department of Health Chief, Office of Immunization Rhode Island School Immunization Regulations.
Recommendations on IAP Immunization Time Table for 2012 Vipin M. Vashishtha, MD, FIAP Convener, IAPCOI December 24 th, 25.
Challenges:  Patient Age  Live virus or split virus  Preservative free or with preservative  Combo vaccine or individual vaccine  Route of administration.
Adult Immunization 2010 Meningococcal Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.
What's New on the Child and Adolescent Immunization Schedules William L. Atkinson, MD, MPH National Center for Immunization and Respiratory Diseases William.
Childhood Immunization Update for WIC and Clerical Personnel Presented by: Date:
MEASLES VACCINATION 2015 Update Susan Reeser RN, BSN (406)
1 1 Immunization Update 2011 Connecticut Immunization Teleconference April 19, 2011 William Atkinson, MD, MPH National Center for Immunization and Respiratory.
Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.
Child Care Provider Parents Siblings GrandparentsHealthcare Worker.
TM 2011 Immunization Recommendations H. Cody Meissner, M.D. Professor of Pediatrics Tufts University School of Medicine Boston Floating Hospital for Children.
Splenectomy Vaccine Protocol PIDPIC Rationale Spleen clears encapsulated bacteria and infected erythrocytes Serves as one of the largest lymphoid.
North Carolina Immunization Program: Basics & Beyond.
1 Making Sense of New Vaccine Recommendations Vermont Immunization Conference Stowe, Vermont October 28, 2011 William Atkinson, MD, MPH National Center.
Haemophilus influenzae type B and Hib Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
Economic Evaluation of Routine Childhood Immunization with DTaP, Hib, IPV, MMR and HepB Vaccines in the United States, 2001 Fangjun Zhou Health Services.
Immunization Schedule for Filipino children. Objectives To present the 2013 Immunization schedule for Filipino children with focus on –Minimum age for.
5th Annual Advocacy Project: ImmuneWise Section on Medical Students, Residents, and Fellowship Trainees
Better Health. No Hassles. Get Immunized! National Immunization Month.
Vaccination of Adolescents: New Frontiers Andrew Kroger National Center for Immunization and Respiratory Diseases National Assembly on School- based Health.
Vaccines For Children Coordinator Connecticut Immunization Program 1.
MENINGOCOCCAL PNEUMOCOCCAL TETANUS, DIPHTHERIA, PERTUSSIS VARICELLA HEPATITIS A HEPATITIS B HUMAN PAPILLOMA VIRUS Anyone starting at 6 mos old y/o.
 Definition of Immunization  Immunization Schedule  Success of Immunization Assessment of Success Factors Influencing Success  The Cold Chain.
IMMUNITY IMMYNIZATION IMMUNITY. Active immunity are defenses developed by the body that last many years or even a life time. Active immunity are defenses.
BCG Vaccine Usual reactions induration: 2 – 4 wks pustule formation: 5 – 7 wks scar formation: 2 – 3 months Accelerated Reactions: induration: 2-3 days.
NEW CONCEPT OF NEW VACCINE. Airborne vaccine A. Varicella Vaccine:  Type: live attenuated vaccine.  Administration: 0.5 ml s.c  Immunity: 85%-90% for.
Immunization Update 2007 Satellite Broadcast/Webcast August 9, 2007 Influenza Vaccine Segment Graphics subject to change. This material in the public domain.
MENINGOCOCCAL POLYSACCHARIDE PNEUMOCOCCAL POLYSACCHARIDE TETANUS, DIPHTHERIA, PERTUSSIS VARICELLA HEPATITIS A HEPATITIS B HUMAN PAPILLOMA VIRUS Anyone.
Troi Cunningham, RN Kentucky Immunization Program October 2015.
Date of download: 5/27/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. CDC adult immunization based on vaccine and indications. Notes:
Date of download: 5/27/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Recommended adult immunization schedules, United States, 2011.
Date of download: 5/27/2016 From: Recommended Adult Immunization Schedule: United States, 2009(1) Ann Intern Med. 2009;150(1): doi: /
What is a vaccine? A vaccine is a medicine that's given to help prevent a disease. Vaccines help the body produce antibodies. These antibodies protect.
CHILDHOOD IMMUNIZATION
Job Corps Webinar: Immunizations John Kulig MD MPH Lead Medical Specialist September 29 & 30, 2010.
Haemophilus influenzae type B and Hib Vaccine
Date of download: 6/21/2016 From: Recommended Adult Immunization Schedule: United States, October 2007–September 2008(1) Ann Intern Med. 2007;147(10):
Tips and Tricks: Child/Adolescent Immunization Schedule Candice Robinson, MD, MPH Medical officer March 16, 2016 National Center for Immunization & Respiratory.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory.
Prevention of Perinatal Hepatitis B in New York City Julie E. Lazaroff, MPH Unit Chief Perinatal Hepatitis B Prevention Unit Bureau of Immunization NYC.
Guidelines for Vaccinating Dialysis Patients BY: DR. JONAIDI ASSOCIATE PROF. OF INFECTIOUS DISEASES.
Methods of Infection Prevention in Advanced HIV Care Francesca Conradie President of the Southern African HIV Clinicians Society.
What’s Up With All Those Other Vaccines?
Vaccination د.رائد كريم العكيلي.
© I.M.Quizitor Pediatrics Date.
iHepatitis A vaccine (HepA)
CHILDHOOD IMMUNIZATION
VACCINES IMMUNISATION IN ADULTS
Footnotes — Recommended immunization schedule for persons aged 0 through 18 years—United States, 2014 For further guidance on the use of the vaccines mentioned.
2010 Tennessee Immunization Requirements for School Entrance:
What’s New with Vaccines
What’s New in Adult Immunization
Immunization FaQs 2018 Amy Bachyrycz.
Combination and Special Circumstance Vaccines
Number of catch-up doses needed (n = 200) at admission and at 1-month follow-up by vaccine type among 95 children found to be underimmunized per ACIP guidelines.
Vaccination coverage of U. S
Healthy People 2010 Focus Area 14
The Texas Child Care Immunization Assessment Survey
Presentation transcript:

Date of download: 6/22/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Notes: aHepatitis B vaccine (HepB). AT BIRTH: All newborns should receive monovalent HepB soon after birth and before hospital discharge. Infants born to mothers who are HBsAg-positive should receive HepB and 0.5 mL of hepatitis B immune globulin (HBIG) within 12 hours of birth. Infants born to mothers whose HBsAg status is unknown should receive HepB within 12 hours of birth. The mother should have blood drawn as soon as possible to determine her HBsAg status; if the result is HBsAg-positive, the infant should receive HBIG as soon as possible (no later than age 1 wk). For infants born to HBsAg-negative mothers, the birth dose can be delayed in rare circumstances but only if a physician’s order to withhold the vaccine and a copy of the mother’s original HBsAg- negative laboratory report are documented in the infant’s medical record. FOLLOWING THE BIRTHDOSE: The HepB series should be completed with either monovalent HepB or a combination vaccine containing HepB. The second dose should be administered at age 1–2 mo. The final dose should be administered at age ≥24 wks. It is permissible to administer 4 doses of HepB (eg, when combination vaccines are given after the birth dose); however, if monovalent HepB is used, a dose at age 4 mo is not needed. Infants born to HBsAg positive mothers should be tested for HBsAg and antibody to HBsAg after completion of the HepB series, at age 9–18 mo (generally at the next well-child visit after completion of the vaccine series). bDiphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP). The fourth dose of DTaP may be administered as early as age 12 mo, provided 6 mo have elapsed since the third dose and the child is unlikely to return at age 15–18 mo. The final dose in the series should be given at age ≥4 y. Tetanus and diphtheria toxoids and acellular pertussis vaccine (Tdap – adolescent preparation) is recommended at age 11–12 y for those who have completed the recommended childhood DTP/DTaP vaccination series and have not received a Td booster dose. Adolescents 13–18 y who missed the 11–12-y Td/Tdap booster dose should also receive a single dose of Tdap if they have completed the recommended childhood DTP/DTaP vaccination series. Subsequent tetanus and diphtheria toxoids (Td) are recommended every 10 y. cHaemophilus influenzae type b conjugate vaccine (Hib). Three Hib conjugate vaccines are licensed for infant use. If PRP-OMP (PedvaxHIB or ComVax [Merck]) is administered at ages 2 and 4 mo, a dose at age 6 mo is not required. DTaP/Hib combination products should not be used for primary immunization in infants at ages 2, 4 or 6 mo but can be used as boosters after any Hib vaccine. The final dose in the series should be administered at age ≥12 mo. dMeasles, mumps, and rubella vaccine (MMR). The second dose of MMR is recommended routinely at age 4–6 y but may be administered during any visit, provided at least 4 wk have elapsed since the first dose and both doses are administered beginning at or after age 12 mo. Those who have not previously received the second dose should complete the schedule by age 11–12 y. eVaricella vaccine. Varicella vaccine is recommended at any visit at or after age 12 mo for susceptible children (i.e., those who lack a reliable history of chickenpox). Susceptible persons aged ≥13 y should receive 2 doses administered at least 4 wk apart. Continued. fMeningococcal vaccine. Meningococcal conjugate vaccine (MCV4) should be given to all children at the 11–12 y old visit as well as to unvaccinated adolescents at high school entry (15 y of age). Other adolescents who wish to decrease their risk for meningococcal disease may also be vaccinated. All college freshmen living in dormitories should also be vaccinated, preferably with MCV4, although meningococcal polysaccharide vaccine (MPSV4) is an acceptable alternative. Vaccination against invasive meningococcal disease is recommended for children and adolescents aged ≥2 y with terminal complement deficiencies or anatomic or functional asplenia and certain other high risk groups (see MMWR 2005;54[RR-7]:1–21); use MPSV4 for children aged 2–10 y and MCV4 for older children, although MPSV4 is an acceptable alternative. gPneumococcal vaccine. The heptavalent pneumococcal conjugate vaccine (PCV) is recommended for all children aged 2–23 mo and for certain children aged 24–59 mo. The final dose in the series should be given at age ≥12 mo. Pneumococcal polysaccharide vaccine (PPV) is recommended in addition to PCV for certain high-risk groups. See MMWR 2000;49(RR-9):1–35. hInfluenza vaccine. Influenza vaccine is recommended annually for children aged ≥6 mo with certain risk factors (including, but not limited to, asthma, cardiac disease, sickle cell disease, HIV, diabetes, and conditions that can compromise respiratory function or handling of respiratory secretions or that can increase the risk for aspiration), healthcare workers, and other persons (including household members) in close contact with persons in groups at high risk (see MMWR 2005;54[RR-8]:1–55). In addition, healthy children aged 6–23 mo and close contacts of healthy children aged 0–5 mo are recommended to receive influenza vaccine because children in this age group are at substantially increased risk of influenza-related hospitalizations. For healthy persons aged 5–49 y, the intranasally administered, live, attenuated influenza vaccine (LAIV) is an acceptable alternative to the intramuscular trivalent inactivated influenza vaccine (TIV). See MMWR 2005;54(RR-8):1–55. Children receiving TIV should be administered a dosage appropriate for their age (0.25 mL if aged 6–35 mo or 0.5 mL if aged ≥3 y). Children aged ð8 y who are receiving influenza vaccine for the first time should receive 2 doses (separated by at least 4 wk for TIV and at least 6 wk for LAIV). iHepatitis A vaccine (HepA). HepA is recommended for all children at 1 y of age (i.e.,12–23 mo). The 2 doses in the series should be administered at least 6 mo apart. States, counties, and communities with existing HepA vaccination programs for children 2–18 y of age are encouraged to maintain these programs. In these areas, new efforts focused on routine vaccination of 1-y-old children should enhance, not replace, ongoing programs directed at a broader population of children. HepA is also recommended for certain high-risk groups (see MMWR 1999;48[RR-12]:1–37). Legend : From: Appendix Clinician's Pocket Reference: The Scut Monkey, 11e, 2007 From: Appendix Clinician's Pocket Reference: The Scut Monkey, 11e, 2007